March 28, 2024
Current methods for the analysis and reporting of bone marrow aspirate (BMA) specimens are based on analog microscopy. The lack of uniformity between experts in the field, originating from a subjective manual review, can lead to inconsistencies in disease diagnosis and classification, and thereby affect treatment and clinical outcomes. Considering the complexity of the manual BMA analysis, even more so in routine laboratory settings with competitive turnaround times, a digital transformation can sustain the desired standardization, increased sensitivity and efficiency in routine workflow.
The introduction of Scopio’s full field morphological evaluation of BMA smears, promotes an accurate diagnosis haematological disorders including haematological malignancies, and enables a remote evaluation of BMA smears. By reviewing the entire BMA smear, and by counting a very large number of cells, this novel approach provides a new and highly accurate tool for early detection of pathological conditions, including residual disease following therapy.
research
research
poster